Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Joseph Aisner

Joseph Aisner

Person

19742020
No photo of Jyoti Malhotra

Jyoti Malhotra

Person

20122019

Projects 2004 2015

Participation In The Eastern Cooperative Oncology Group

Aisner, J.

National Institutes of Health (NIH)

9/2/04 → 2/28/15

Project: Research project

Chemoprevention
Research Personnel
Clinical Trials
Guideline Adherence
Synthetic Vaccines

Research Output 1974 2020

Paravertebral Nerve Block With Liposomal Bupivacaine for Pain Control Following Video-Assisted Thoracoscopic Surgery and Thoracotomy

NeMoyer, R. E., Pantin, E., Aisner, J., Jongco, R., Mellender, S., Chiricolo, A., Moore, D. F. & Langenfeld, J., Feb 2020, In : Journal of Surgical Research. 246, p. 19-25 7 p.

Research output: Contribution to journal › Article

Video-Assisted Thoracic Surgery
Nerve Block
Bupivacaine
Thoracotomy
Pain
2 Citations (Scopus)

A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib

Castellano, G. M., Aisner, J., Burley, S. K., Vallat, B., Yu, H. A., Pine, S. R. & Ganesan, S., Nov 2019, In : Journal of Thoracic Oncology. 14, 11, p. 1982-1988 7 p.

Research output: Contribution to journal › Article

Exons
Mutation
Lung Neoplasms
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
HM781-36B

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Sep 1 2019, In : Cancer chemotherapy and pharmacology. 84, 3, p. 567-578 12 p.

Research output: Contribution to journal › Article

eribulin
Carboplatin
Non-Small Cell Lung Carcinoma
Labels
Tumors